ingredientNivolumab 100mg
substitutesOpdyta 100mg Injection
treatmentNon-small cell lung cancer, Kidney cancer, Head and neck cancer
shipping classcold chain
Medicine Overview by Anukar Pharmacy
( Opdivo 100mg 1 Injection, Bms )
TreatmentOpdivo 100mg 1 Injection is used in the treatment of non-small cell lung cancer, kidney cancer, head and neck cancer, melanoma, Hodgkin’s disease and liver cancer.
Side EffectsSide Effects of Opdyta are Rash, Weakness, Headache, Fever, Musculoskeletal (bone, muscle or joint) pain, Back pain, Stomach pain, Nausea, Itching, Constipation, Diarrhoea, Upper respiratory tract infection, Decreased appetite, Shortness of breath, Cough.
Method of UseYour doctor or nurse will give you this medicine. Kindly do not self administer.
How WorksOpdivo 100mg 1 Injection is an anti-cancer medication. It works by blocking a protein (PD-1) on the surface of certain immune cells called T-cells. This action activates the T-cells to locate and kill cancer cells.
Warning by Anukar Pharmacy
( Opdivo 100mg 1 Injection, Bms )
Special precautions for ( Opdivo 100mg 1 Injection, Bms ) Heads up
| aspect | highlight | details |
|---|---|---|
alcohol
|
Interaction with Alcohol is unknown. Please consult your doctor. | |
Pregnancy
|
WEIGH RISKS VS BENEFITS | Opdivo 100mg 1 Injection is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor. |
Lactation
|
caution | Opdivo 100mg 1 Injection is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby. |
driving
|
Interaction with Driving is unknown. Please consult your doctor. | |
kidney
|
Interaction with Kidney is unknown. Please consult your doctor. | |
liver
|
Interaction with Liver is unknown. Please consult your doctor. |
Disclaimer
The information of Anukar Pharmacy is for reference purpose only, and Anukar Pharmacy or Anukar Pharmacy or Anukar Pharmacy is not intended to be a replacement of professional medical advice, diagnosis, or treatment. Anukar Pharmacy suggest to ask the advice of a physician or any qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of anything you have learned from Anukar Pharmacy.
| 药名 | 欧狄沃, 纳武利尤单抗, 纳武单抗, O药 |
| 厂家 | Bristol-Myers Squibb Holdings Pharma, Ltd.Liability Company |
| 成分 | 纳武利尤单抗 |
| 说明 |
纳武单抗
Opdivo 纳武利尤单抗（欧狄沃）最早在日本获批，是全球首个上市的PD-1/PD-L1药物，随后该药在2014年4月首次获得FDA批准用于治疗黑色素瘤，迄今为止已经有8个大的肿瘤适应症被FDA批准。纳武单抗 Opdyta 100ml nivolumab适用为有不能切除或转移黑色素瘤; 适用为有转移鳞状非小细胞肺癌(NSCLC)用基于铂化疗或后有转移患者的治疗。
治疗作用：（EGFR）基因突变阴性和间变性淋巴瘤激酶；黑色素瘤、非小细胞肺癌
|
* 以上中文信息由印度阿努卡药房收集的Opdivo 100mg 1 Injection, Bms（欧狄沃, 纳武利尤单抗, 纳武单抗, O药）中文网络信息和软件翻译获得，阿努卡药房认为Opdivo 100mg 1 Injection, Bms（欧狄沃, 纳武利尤单抗, 纳武单抗, O药）中文产品介绍信息存在与Opdivo 100mg 1 Injection, Bms（欧狄沃, 纳武利尤单抗, 纳武单抗, O药）实际数据不一致的可能。阿努卡药房请用户把Opdivo 100mg 1 Injection, Bms（欧狄沃, 纳武利尤单抗, 纳武单抗, O药）页面数据作为参考。印度阿努卡药房建议用户在实际使用Opdivo 100mg 1 Injection, Bms（欧狄沃, 纳武利尤单抗, 纳武单抗, O药）数据或者信息时，以Opdivo 100mg 1 Injection, Bms（欧狄沃, 纳武利尤单抗, 纳武单抗, O药）制造商公开发布的Opdivo 100mg 1 Injection, Bms（欧狄沃, 纳武利尤单抗, 纳武单抗, O药）商品信息为参考。使用方法，以用户医生建议使用Opdivo 100mg 1 Injection, Bms（欧狄沃, 纳武利尤单抗, 纳武单抗, O药）决定为参考。用户任何关于Opdivo 100mg 1 Injection, Bms（欧狄沃, 纳武利尤单抗, 纳武单抗, O药）的建议，可以通知印度阿努卡药房，或通知阿努卡在线客服人员。谢谢
